Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 139-146

  Allan, C A ^a   Strauss, B J G ^a   Burger, H G ^a   Forbes, E A ^a   McLachlan, R I ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; PLACEBO; TESTOSTERONE;

ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAABDOMINAL FAT; MALE; METABOLIC PARAMETERS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAFETY; SKELETAL MUSCLE; TESTOSTERONE BLOOD LEVEL;

EID: 38149032364     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1291     Document Type: Article

References (55)

1. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995-2010
2. Liverman CT, Blazer DG, eds 2003 Testosterone and aging: clinical research directions. Washington, DC: Institute of Medicine of the National Academies
3. Allan CA, McLachlan RI 2004 Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 60:653-670
4. Gruenewald DA, Matsumoto AM 2003 Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 51:101-115; discussion 115
5. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2005 Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90:1502-1510
6. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R 2003 AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 88:2673-2681
7. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653
8. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG 2001 Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56:M266-M272
9. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE 2003 Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58:618-625
10. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton 3rd LJ, Smith GE, Khosla S, Jensen MD 2006 DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659
11. Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, McMillan CV, Bradley C, Martin FC 2006 The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 91:477-484
12. Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS 2002 The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab 87:1467-1472
13. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ 2002 Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601-E607
14. Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR 2004 Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab 89:4863-4872
15. Schroeder ET, Singh A, Bhasin S, Storer TW, Azen C, Davidson T, Martinez C, Sinha-Hikim I, Jaque SV, Terk M, Sattler FR 2003 Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. Am J Physiol Endocrinol Metab 284:E120-E128
16. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997
17. Marin P, Holmang S, Gustafsson C, Jonsson L, Kvist H, Elander A, Eldh J, Sjostrom L, Holm G, Bjorntorp P 1993 Androgen treatment of abdominally obese men. Obes Res 1:245-251
18. Munzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF, Stevens TE, O'Connor KG, Pabst KM, St. Clair C, Sorkin JD, Blackman MR 2001 Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 86:3604-3610
19. Villareal DT, Holloszy JO 2004 Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243-2248
20. Liu PY, Swerdloff RS, Veldhuis JD 2004 Clinical review 171: the rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89:4789-4796
21. World Health Organization 1997 Obesity - preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva: World Health Organization
22. Tenover JL 1998 Male hormone replacement therapy including "andropause." Endocrinol Metab Clin North Am 27:969-987, x
23. Tremblay RR, Morales A 1998 Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency. Aging Male 1:1368-5538
24. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
25. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D 2002 Total-body skeletal muscle mass: estimation by a new dual-energy x-ray absorptiometry method. Am J Clin Nutr 76:378-383
26. Ross R, Leger L, Morris D, de Guise J, Guardo R 1992 Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72:787-795
27. Barry MJ 2001 Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology 58:25-32; discussion 32
28. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI 2006 The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Med J Aust 185:424-427
29. Gray A, Feldman HA, McKinlay JB, Longcope C 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025
30. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB 2007 The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92:549-555
31. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ 2005 Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab 90:5928-5936
32. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E, Brabant G 2000 Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 53:689-695
33. Morley JE, Patrick P, Perry 3rd HM 2002 Evaluation of assays available to measure free testosterone. Metabolism 51:554-559
34. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ 2001 A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86:4078-4088
35. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2004 Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503-510
36. Forbes GB, Reina JC 1970 Adult lean body mass declines with age: some longitudinal observations. Metabolism 19:653-663
37. Janssen I, Heymsfield SB, Wang ZM, Ross R 2000 Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 89:81-88
38. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW 2005 Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90:678-688
39. Kyle UG, Genton L, Hans D, Karsegard L, Slosman DO, Pichard C 2001 Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 55:663-672
40. Lee SJ, Janssen I, Heymsfield SB, Ross R 2004 Relation between whole-body and regional measures of human skeletal muscle. Am J Clin Nutr 80:1215-1221
41. Baumgartner RN, Rhyne RL, Garry PJ, Heymsfield SB 1993 Imaging techniques and anatomical body composition in aging. J Nutr 123:444-448
42. Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Despres JP, Bouchard C 2000 Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab 85:1026-1031
43. Schleich F, Legros JJ 2004 Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male. Eur J Endocrinol 151:415-424
44. Tenover JL 2000 Experience with testosterone replacement in the elderly. Mayo Clin Proc 75(Suppl):S77-S81; discussion S82
45. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS 2001 Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261-269
46. Kenny AM, Prestwood KM, Gruman CA, Fabregas G, Biskup B, Mansoor G 2002 Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57:M460-M465
47. Bravata DM, Wells CK, Concato J, Kernan WN, Brass LM, Gulanski BI 2004 Two measures of insulin sensitivity provided similar information in a U.S. population. J Clin Epidemiol 57:1214-1217
48. Kapoor D, Goodwin E, Channer KS, Jones TH 2006 Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154:899-906
49. Dobs AS, Bachorik PS, Arver S, Meikle AW, Sanders SW, Caramelli KE, Mazer NA 2001 Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. J Clin Endocrinol Metab 86:1026-1033
50. Parker S, Armitage M 1999 Experience with transdermal testosterone replacement therapy for hypogonadal men. Clin Endocrinol (Oxf) 50:57-62
51. Wilson DE, Kaidbey K, Boike SC, Jorkasky DK 1998 Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther 20:299-306
52. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438
53. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P 1996 Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men andwomenin eastern Finland. Circulation 93:1372-1379
54. Visscher TL, Seidell JC, Menotti A, Blackburn H, Nissinen A, Feskens EJ, Kromhout D 2000 Underweight and overweight in relation to mortality among men aged 40-59 and 50-69 years: the Seven Countries Study. Am J Epidemiol 151:660-666
55. Allan CA, Strauss BJ, McLachlan RI 2007 Body composition, metabolic syndrome and testosterone in ageing men. Int J Impot Res 19:448-457